Abstract
We aim to investigate the relationship between serum somatostatin (SST) levels and glucose-lipid metabolism at various stages of glucose tolerance in the Jino ethnic minority (n=111) and Han population (n=113) of Yunnan Province, southwest China. Anthropometric parameters and biochemical traits were measured. Serum SST and plasma glucagon levels were tested. Participants were divided into three subgroups: isolated fasting hyperglycemia (IFH), isolated post challenge hyperglycemia (IPH) and normal glucose tolerance (NGT). SST levels were found lower while glucagon levels were significantly higher in the Jino ethnic with IPH (P=0.0026 and P=0.0069, respectively). Fasting glucose and high density lipoprotein-cholesterol (HDL-C) levels were higher (P=0.0055 and P=0.0021, respectively) and fasting insulin levels and homeostasis model assessments β-cell function were lower (P=0.0479 and P=0.0007, respectively) in the Jino population. After adjusting for confounding factors, the serum SST level was associated with glucagon (P<0.0001) in both populations. The SST level was correlated with fasting Cpeptide (P=0.0267) in Jino and HDL-C levels in Han (P=0.0079). Our findings suggest that serum SST levels and plasma glucagon levels may vary in subjects with IPH between two ethnics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberti, K.G.M.M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., and rskov, H. (1973). Inhibition of insulin secretion by somatostatin. Lancet 302, 1299–1301.
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., and Guillemin, R. (1973). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179, 77–79.
Christensen, S.E., Hansen, A.P., Orskov, H., and Lundbaek, K. (1978). Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics. Metabolism 27, 1427–1431.
De Martino, M.C., Hofland, L.J., and Lamberts, S.W. (2010). Somatostatin and somatostatin receptors: from basic concepts to clinical applications. Prog Brain Res 182, 255–280.
Efendic, S., Claro, A., and Laft, R. (1976). Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas. Acta Endocrinol (Copenh) 81, 753–761.
Elliott, A.D., Ustione, A., and Piston, D.W. (2015). Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic a- cell by lowering cAMP. Am J Physiol Endocrinol Metab 308, E130–E143.
Escola-Gil, J.C., Julve, J., Griffin, B.A., Freeman, D., and Blanco-Vaca, F. (2015). HDL and lifestyle interventions. Handb Exp Pharmacol 224, 569–592.
Foxx-Orenstein, A., Camilleri, M., Stephens, D., and Burton, D. (2003). Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 52, 1555–1561.
Gosmanov, N.R., Szoke, E., Israelian, Z., Smith, T., Cryer, P.E., Gerich, J. E., and Meyer, C. (2005). Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 28, 1124–1131.
Hadjidakis, D.J., Halvatsiotis, P.G., Ioannou, Y.J., Mavrokefalos, P.J., and Raptis, S.A. (1988). The effects of the somatostatin analogue SMS 201–995 on carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas. Diabetes Res Clin Pract 5, 91–98.
Hao, G., Wang, Z., Zhang, L., Chen, Z., Wang, X., Guo, M., Tian, Y., Shao, L., and Zhu, M. (2015). Relationship between alcohol consumption and serum lipid profiles among Middle-Aged Population in China: a multiple- center cardiovascular epidemiological study. Angiology 66, 753–758.
Hauge-Evans, A.C., King, A.J., Carmignac, D., Richardson, C.C., Robinson, I.C.A.F., Low, M.J., Christie, M.R., Persaud, S.J., and Jones, P.M. (2009). Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 58, 403–411.
Heding, L.G. (1971). Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7, 10–19.
Jiang, F.S., Hou, X.H., Yang, L.P., Li, M., Sun, Q.Y., Lu, H.J., and Jia, W.P. (2016). Prevalence of diabetes and related factors in jinuo ethnic adults of yunnan province. Disease Surveill 31, 598–602.
Li, R., Yu, L., Zhang, X., Zhou, X., Wang, M., and Zhao, H. (2015). Distribution of Islet hormones in human adult pancreatic ducts. Digestion 91, 174–179.
Ma, R.C.W., Lin, X., and Jia, W. (2014). Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol 2, 980–991.
Malaisse, W.J. (2014). Paracrine control of glucagon release by somatostatin (Review). Int J Mol Med 33, 491–498.
Mckillop, A.M., Ng, M.T., Abdelwahab, Y.H., and Flatt, P.R. (2014). Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic ß-cell function and insulin secretion. Diabetes Obesity Metab 16, 937–946.
Patel, Y.C., and Reichlin, S. (1978). Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology 102, 523–530.
Saltiel, A.R. (2016). Insulin signaling in the control of glucose and lipid homeostasis. Handb Exp Pharmacol 233, 51–57.
Santos-Silva, J.C., Ribeiro, R.A., Vettorazzi, J.F., Irles, E., Rickli, S., Borck, P.C., Porciuncula, P.M., Quesada, I., Nadal, A., Boschero, A.C., et al. (2015). Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls ß, a, and d- cell masses in genetic obese mice. Amino Acids 47, 1533–1548.
Sherwin, R.S., Hendler, R., Defronzo, R., Wahren, J., and Felig, P. (1977). Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Proc Natl Acad Sci USA 74, 348–352.
Si, M.W., Yang, M.K., and Fu, X.D. (2015). Effect of hypothalamic-pituitary- adrenal axis alterations on glucose and lipid metabolism in diabetic rats. Genet Mol Res 14, 9562–9570.
Stumvoll, M., Van Haeften, T., Fritsche, A., and Gerich, J. (2001). Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24, 796–797.
Van Op den Bosch, J., Adriaensen, D., Van Nassauw, L., and Timmermans, J.P. (2009). The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review. Regul Peptides 156, 1–8.
Wang, S., Zhang, R., Xiang, G., Li, Y., Hou, X., Jiang, F., Jiang, F., Hu, C., and Jia, W. (2015). Mutation screening for thalassaemia in the Jino ethnic minority population of Yunnan Province, Southwest China. BMJ Open 5, e010047.
Wenger, F.A., Kilian, M., Mautsch, I., Jacobi, C.A., Steiert, A., Peter, F.J., Guski, H., Schimke, I., and Müller, J.M. (2001). Influence of octreotide on liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in syrian hamsters. Pancreas 23, 266–272.
Wild, S., Roglic, G., Green, A., Sicree, R., and King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053.
Xu, J., Liao, Y., Liu, H., Nie, R., and Havumaki, J. (2014). Use of bed nets and factors that influence bed net use among Jinuo Ethnic Minority in Southern China. PLoS ONE 9, e103780.
Yang, J.Z., Kang, C.Y., Zeng, Y., Li, J.H., Li, P.K., Wan, W.P., Zhao, X.D., Guo, W.J., Xu, X.F., Yang, X.B., et al. (2014). Prevalence and prognosis of schizophrenia in Jinuo people in China: a prospective 30-year followup study. Int J Soc Psychiatry 60, 482–488.
Yang, W.Y., Lu, J.M., Weng, J.P., Jia, W.P., Ji, L.N., Xiao, J.Z., Shan, Z.Y., Liu, J., Tian, H.M., Ji, Q., et al. (2010). Prevalence of diabetes among men and women in China. N Engl J Med 362, 1090–1101.
Zhang, H., Han, T., Sun, L.N., Huang, B.K., Chen, Y.F., Zheng, H.C., and Qin, L.P. (2008). Regulative effects of essential oil from Atractylodes lancea on delayed gastric emptying in stress-induced rats. Phytomedicine 15, 602–611.
Zhang, J., McKenna, L.B., Bogue, C.W., and Kaestner, K.H. (2014). The diabetes gene Hhex maintains delta-cell differentiation and islet function. Genes Dev 28, 829–834.
Acknowledgements
We want to acknowledge Radioimmunology and Clinical Laboratory (Luwan Branch of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine) for providing technical support. This work was supported by the National Natural Science Foundation of China (91331110), the Innovation Fund for PhD Students from Shanghai Jiao Tong University School of Medicine (BXJ201738), the Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine (15ZH4006) and Shanghai SJTUSM Biobank. We thank all the research subjects for their participation and the skillful work of all the medical staff at the Shanghai Clinical Center for Diabetes.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Table S1
The comparisons of clinical characteristics between two ethnics at various stages of glucose tolerance.
Rights and permissions
About this article
Cite this article
Wang, S., Zhang, R., Hou, X. et al. Association between serum somatostatin levels and glucose-lipid metabolism in the Jino ethnic minority and Han Chinese population. Sci. China Life Sci. 61, 1382–1388 (2018). https://doi.org/10.1007/s11427-017-9289-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-017-9289-7